Evidence map›Paper›PMID 27167171›Full record

ArticleJournal of visualized experiments : JoVE2016

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions.

Kristin Derlig, Andreas Gießl, Johann Helmut Brandstätter, Ralf Enz, Regina Dahlhaus

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kristin DerligInstitute for Biochemistry, Emil-Fischer Centre, University of Erlangen-Nuremberg.
Andreas GießlDepartment of Biology, Animal Physiology, University of Erlangen-Nuremberg.
Johann Helmut BrandstätterDepartment of Biology, Animal Physiology, University of Erlangen-Nuremberg.
Ralf EnzInstitute for Biochemistry, Emil-Fischer Centre, University of Erlangen-Nuremberg.
Regina DahlhausInstitute for Biochemistry, Emil-Fischer Centre, University of Erlangen-Nuremberg; rdahlhaus@hotmail.com.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEFischer (Germany) · DE

Funding

CIHR
6 · The paper itself

Abstract

A strict management of protein expression is not only essential to every organism alive, but also an important strategy to investigate protein functions in cellular models. Therefore, recent research invented different tools to target protein expression in mammalian cell lines or even animal models, including RNA and antibody interference. While the first strategy has gathered much attention during the past two decades, peptides  mediating a translocation of antibody cargos across cellular membranes and into cells, obtained much less interest. In this publication, we provide a detailed protocol how to utilize a peptide carrier named Chariot in human embryonic kidney cells as well as in primary hippocampal neurons to perform antibody interference experiments and further illustrate the application of three-dimensional reconstructions in analyzing protein function. Our findings suggest that Chariot is, probably due to its nuclear localization signal, particularly well-suited to target proteins residing in the soma and the nucleus. Remarkably, when applying Chariot to primary hippocampal cultures, the reagent turned out to be surprisingly well accepted by dissociated neurons.

Indexed as

AntibodiesCell LineCell NucleusCysteamineHEK293 CellsHippocampusHumansNeuronsNuclear ProteinsPeptidesProtein BiosynthesisRNAAntibodiesCysteamineNuclear ProteinsPep-1 peptidePeptidesRNA

Identifiers

PMID27167171
PMCPMC4941955
OpenAlexW2339767903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.